Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

On Mar 9, Zacks Investment Research upgraded Blackbaud Inc. (BLKB - Snapshot Report) to Zacks Rank #1 (Strong Buy).

Why the Upgrade?

Blackbaud has been witnessing rising earnings estimates on the back of strong fiscal fourth-quarter 2012 results and encouraging full-year 2013 outlook. Moreover, this well-known software solutions provider delivered positive earnings surprise in the last quarter with a surprise of 58.8%. The long-term expected earnings growth rate for this stock is 15.0%    

Blackbaudreported fiscal fourth-quarter (ended Dec 31, 2012) results on Feb 13, 2013. Non-GAAP earnings per share came in at 27 cents, surpassing the Zacks Consensus Estimate and year-ago earnings of 17 cents by 58.8%.

Each of the company’s business units performed well during the quarter and the recent acquisition of Convio was accretive to the earnings with its Luminate product line. In addition, the company also gained through its go-to-market strategies.  

Earnings growth, both year-over-year and sequentially, were primarily driven by disciplined cost management and significant cost synergies from the Covio acquisition.

Based on its progress, the company provided an encouraging guidance for full year 2013. For the full year 2013, Blackbaud expects total non-GAAP revenue in the range of $495 million to $505 million.

Revenue guidance takes into account a negative impact of approximately $6 million related to incremental progress rationalizing and integrating the product suite and due to changing contractual terms with the company’s product partner in the ticketing area, which requires it to move from gross to net revenue recognition for sales in the related solution. However, this adjustment will have no impact on the profitability.

Non-GAAP operating margin is expected in the range of 19% to 19.5%, reflecting approximately 250 basis points growth from the prior year.

The Zacks Consensus Estimate for fiscal 2013 increased 8.6% to 88 cents per share as most of the estimates were revised higher over the last 30 days.

Other Stocks to Consider

The following software solution providers with favorable Zacks Rank are also performing well and are worth considering.

  • Symantec Corp. (SYMC - Analyst Report) carries a Zacks #1 Rank (Strong Buy)
  • Synopsis Inc. (SNPS - Analyst Report) carries a Zacks #1 Rank (Strong Buy)                
  • Pervasive Software Inc. carries a Zacks #1 Rank (Strong Buy)

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
CELL THERAPE CTIC 3.18 +6.19%
DIXIE GROUP DXYN 15.48 +5.45%
BOFL HOLDING BOFI 85.45 +5.16%
RAMBUS INC RMBS 12.36 +4.83%
SHORETEL INC SHOR 8.06 +3.47%